BioCentury
ARTICLE | Company News

Roslin Cells, Pfizer deal

July 18, 2011 7:00 AM UTC

Pfizer will evaluate Roslin's GMP pluripotent stem cell lines for potential use in clinical therapies. Details were not disclosed. ...